Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -62.98% is 499% below its 5-year average of -10.51%, near the high end of its 5-year range (-777.27%–58.02%).
77.69% above its 12-month average of -282.28%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
-62.98%
NET PROFIT MARGIN AVG TTM
-282.28%
NET PROFIT MARGIN AVG 3Y
-96.04%
NET PROFIT MARGIN AVG 5Y
-10.51%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+77.69%
CURRENT VS 3Y AVG
+34.42%
CURRENT VS 5Y AVG
-499.46%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.98%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-801.34%
vs the sector median at left
BioNTech SE
Market Cap
$24.67B
Net Profit Margin
-62.98%
TTM Avg
-282.28%
3Y Avg
-96.04%
5Y Avg
-10.51%
Market Cap
$23.84B
Net Profit Margin
16.98%
TTM Avg
16.55%
3Y Avg
18.38%
5Y Avg
18.84%
Market Cap
$25.71B
Net Profit Margin
27.71%
TTM Avg
12.90%
3Y Avg
13.00%
5Y Avg
12.11%
Market Cap
$25.90B
Net Profit Margin
9.19%
TTM Avg
8.91%
3Y Avg
9.15%
5Y Avg
11.71%
Market Cap
$26.18B
Net Profit Margin
21.91%
TTM Avg
21.94%
3Y Avg
21.74%
5Y Avg
21.20%
Market Cap
$26.36B
Net Profit Margin
6.99%
TTM Avg
6.01%
3Y Avg
6.56%
5Y Avg
9.24%
Market Cap
$21.45B
Net Profit Margin
41.56%
TTM Avg
41.73%
3Y Avg
40.84%
5Y Avg
37.71%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioNTech SE (BNTX) | $24.67B | -62.98% | -282.28% | -96.04% | -10.51% |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.84B | 16.98% | 16.55% | 18.38% | 18.84% |
| Incyte Corporation (INCY)vs › | $25.71B | 27.71% | 12.90% | 13.00% | 12.11% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.90B | 9.19% | 8.91% | 9.15% | 11.71% |
| Mettler-Toledo International Inc. (MTD)vs › | $26.18B | 21.91% | 21.94% | 21.74% | 21.20% |
| Labcorp Holdings Inc. (LH)vs › | $26.36B | 6.99% | 6.01% | 6.56% | 9.24% |
| United Therapeutics Corporation (UTHR)vs › | $21.45B | 41.56% | 41.73% | 40.84% | 37.71% |
| STERIS plc (STE)vs › | $21.03B | 13.33% | 12.25% | 8.55% | 8.79% |
| Medline Inc. (MDLN)vs › | $28.80B | 2.31% | 4.39% | 2.42% | 2.42% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.54B | 7.86% | 10.12% | 9.68% | 22.03% |
Operating Margin
-22.6%
Net Profit Margin
-63.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -777.27% |
| 2026-03-31 | -450.38% |
| 2025-12-31 | -33.61% |
| 2025-09-30 | -1.89% |
| 2025-06-30 | -148.24% |
| 2025-03-31 | -227.46% |
| 2024-12-31 | 21.81% |
| 2024-09-30 | 15.91% |
| 2024-06-30 | -627.66% |
| 2024-03-31 | -167.96% |
| 2023-12-31 | 30.96% |
| 2023-09-30 | 17.94% |
| 2023-06-30 | -113.54% |
| 2023-03-31 | 39.33% |
| 2022-12-31 | 53.26% |
| 2022-09-30 | 51.57% |
| 2022-06-30 | 52.31% |
| 2022-03-31 | 58.02% |
| 2021-12-31 | 57.23% |
| 2021-09-30 | 52.75% |
| 2021-06-30 | 52.50% |
| 2021-03-31 | 55.07% |
| 2020-12-31 | 106.22% |
| 2020-09-30 | -311.11% |
| 2020-06-30 | -211.75% |
| 2020-03-31 | -192.78% |
| 2019-12-31 | -208.03% |
| 2019-09-30 | -105.03% |
| 2019-06-30 | -194.24% |
| 2019-03-31 | -155.41% |
| 2018-12-31 | -2.12% |
| 2018-09-30 | -114.88% |
| 2018-06-30 | -53.54% |
| 2018-03-31 | -53.54% |
